Posted by Michael Wonder on 27 Feb 2016

Highlights from the CHMP meeting - 22-25 February 2016

26 February 2016 - The European Medicines Agency’s CHMP recommended six new medicines for marketing authorisation at its February 2016 meeting.

For more details, go to: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/02/news_detail_002474.jsp&mid=WC0b01ac058004d5c1

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , Europe , Blood product